CLSA was recently featured in BOSS Magazine regarding our efforts to drive solution-oriented public policies and advocacy activities that sustain and support life sciences research, investment and innovation in California. View the executive profile for more.
New Digital Advocacy “Take Action” Center helps members stay informed about CLSA’s advocacy efforts, view priority legislation, contact their elected officials and more.
Imagine not being able to always control the movements of your body. Not being able to control your hand or foot movements. Imagine smacking your lips and blinking excessively or not being able to control your tongue. Would this impact your social interactions? Your work? Your relationships? Your self-confidence? These uncontrollable symptoms are experienced daily … Continue reading San Diego Life Sciences Company Tackles Debilitating Disorder
There are nearly 7,000 identified rare diseases, affecting 35 million Americans and more than 350 million individuals worldwide. If all of the people with a rare disease lived in one country, it would be the world’s 3rd most populous country. Approximately 50% of the people affected by rare diseases are children, and 35% of children … Continue reading Five Things You Should Know – About Rare Diseases
BIO 2017 returns to San Diego in June – are you ready? For a limited time – until January 31st ONLY — CLSA members can take advantage of a 20% discount code for registration. Contact us to get your code! Did you know Rare Disease Day and American Heart Month both fall in the month … Continue reading Five Things You Should Know – January 2017
Written By: Sara Radcliffe President & CEO CLSA – California Life Sciences Association December 22, 2016 December is often a reflective time, as we close out one year and prepare for the next. 2016 was a year of hard work, surprising events and inspiring achievements, and the team at CLSA would like to share the key highlights … Continue reading 2016 – CLSA Year in Review
CLSA is pleased to provide you with this exclusive 2016 federal, state and local election update, and what these results mean for California’s life sciences sector.
California Life Sciences Association Partners with LA BioMed and Lab Launch to Grow World-Class Life Sciences Innovation Hub in Los Angeles; Opens Los Angeles Office
CLSA & OCTANe today announced a formal alliance to strategically accelerate the growth of Orange County’s life sciences sector.
With 17 propositions on California’s November ballot, there is one that stands out as particularly bad for patients, veterans and taxpayers: Proposition 61. Prop. 61 is a deceptive, deeply-flawed measure that will increase prescription drug costs, jeopardize patient access to medicines and result in more bureaucracy, red tape and lawsuits that will cost taxpayers millions. … Continue reading Prop. 61: Bad for Patients, Harmful to Veterans, Expensive for Taxpayers